<?xml version="1.0" encoding="UTF-8" ?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">


<journal>
<language>en</language>
<journal_id_issn>1726-7536</journal_id_issn>
<journal_id_issn_online>1735-8507</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi></journal_id_doi>
<journal_id_isnet></journal_id_isnet>
<journal_id_iranmedex>69</journal_id_iranmedex>
<journal_id_magiran>2139</journal_id_magiran>
<journal_id_sid>288</journal_id_sid>
<pubdate PubStatus="epublish">
	<type>gregorian</type>
	<year>2015</year>
	<month>6</month>
	<day>23</day>
</pubdate>
<volume>16</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>26913234</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>Progesterone/Estradiol Ratio as a Predictor in the ART Cycles with Premature Progesterone Elevation on the Day of hCG Trigger</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;Background: The purpose of the study was to evaluate the role of Progesterone/ Estradiol (P&lt;sub&gt;4&lt;/sub&gt;/E&lt;sub&gt;2&lt;/sub&gt;) ratio as a predictive tool for clinical pregnancy in ART cycles with a premature progesterone rise of &amp;gt;1.5&lt;em&gt; ng/ml&lt;/em&gt; on the day of human chorionic gonadotropin (hCG) trigger.&lt;br /&gt;
Methods: Retrospective analysis was done on 569 fresh embryo transfer cycles from January 2011 to December 2012 at the infertility unit of a tertiary care hospital. Age, BMI, number of cycles and number of clinical pregnancies have been considered.&lt;br /&gt;
Results: The overall clinical pregnancy rate per embryo transfer was 42.8% (244/569). The clinical pregnancy rate in the 36 cycles with progesterone (P&lt;sub&gt;4&lt;/sub&gt;) level &amp;gt;1.5 &lt;em&gt;ng/ml &lt;/em&gt;was significantly lower than the 533 cycles with normal p&lt;sub&gt;4&lt;/sub&gt; &amp;le;1.5 &lt;em&gt;ng/ml&lt;/em&gt; (22.2% &lt;em&gt;vs&lt;/em&gt;. 44.2%; p=0.0092). The 36 cycles with progesterone level &amp;gt;1.5 &lt;em&gt;ng/ml&lt;/em&gt; were divided into subgroups of P&lt;sub&gt;4&lt;/sub&gt;/E&lt;sub&gt;2&lt;/sub&gt; &amp;gt;1 (n=20) and P&lt;sub&gt;&lt;em&gt;4&lt;/em&gt;&lt;/sub&gt;/E&lt;sub&gt;&lt;em&gt;2&lt;/em&gt;&lt;/sub&gt; &amp;le;1 (n=16). The 20 cycles with P&lt;sub&gt;4&lt;/sub&gt;/E&lt;sub&gt;2&lt;/sub&gt; &amp;gt;1 and P&lt;sub&gt;4&lt;/sub&gt; &amp;gt;1.5 &lt;em&gt;ng/ml&lt;/em&gt; had a significantly lower pregnancy rate than the cycles with P&lt;sub&gt;4&lt;/sub&gt; &amp;le;1.5 &lt;em&gt;ng/ml&lt;/em&gt; (15% vs. 42.8%; p=0.0103). The 15 cycles with P&lt;sub&gt;4&lt;/sub&gt;/E&lt;sub&gt;2&lt;/sub&gt; &amp;le;1 and P&lt;sub&gt;4&lt;/sub&gt; &amp;gt;1.5 &lt;em&gt;ng/ml&lt;/em&gt; had a similar pregnancy rate as the cycles with P&lt;sub&gt;4&lt;/sub&gt; &amp;le;1.5 &lt;em&gt;ng/ml.&lt;/em&gt;&lt;br /&gt;
Conclusion: A premature progesterone elevation in ART cycles is possibly associated with lower clinical pregnancy rates; this adverse impact of elevated progesterone seems to be limited mainly to a subgroup with an elevated P&lt;sub&gt;4&lt;/sub&gt;/E&lt;sub&gt;2&lt;/sub&gt; ratio &amp;gt;1.&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>ART, Pregnancy, Premature progesterone elevation</keyword>
	<start_page>155</start_page>
	<end_page>162</end_page>
	<web_url>https://www.jri.ir/article/627</web_url>
	<pdf_url>https://www.jri.ir/documents/fullpaper/en/627.pdf</pdf_url>
	<author_list><author><first_name>Mariano</first_name><middle_name></middle_name><last_name>Mascarenhas</last_name><suffix></suffix><affiliation>Reproductive Medicine Unit, Christian Medical College, Vellore, India</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>1429</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Mohan</first_name><middle_name></middle_name><last_name>Kamath</last_name><suffix></suffix><affiliation>Reproductive Medicine Unit, Christian Medical College, Vellore, India</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email>dockamz@gmail.com</email><code>1430</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Achamma</first_name><middle_name></middle_name><last_name>Chandy</last_name><suffix></suffix><affiliation>Reproductive Medicine Unit, Christian Medical College, Vellore, India</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>1431</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Aleyamma</first_name><middle_name></middle_name><last_name>Kunjummen</last_name><suffix></suffix><affiliation>Reproductive Medicine Unit, Christian Medical College, Vellore, India</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>1432</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

</articleset>
</journal>

